ADVA Biotechnology and Cellipont Bioservices Collaborate to Showcase Automated CAR-T Manufacturing at Advanced Therapies Week 2025
ADVA Biotechnology and Cellipont Bioservices collaborate to showcase their successful transition of a CAR-T process from manual to automated manufacturing at Advanced Therapies Week 2025. Learn how this collaboration is revolutionizing cell therapy production for faster treatment delivery.
This news matters as it showcases how innovative technologies and collaborations can revolutionize cell therapy manufacturing, ultimately leading to faster and more reliable production of life-saving treatments for patients worldwide.